Subo, Jaihana A.
HRN: 20-78-59 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/18/2023
NYSTATIN 100,000IU/ML, 30ML SUSPENSION (BOT)
02/18/2023
02/24/2023
PO
1ml
3 X A Day
PCAP-C
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes